Economics
The Only Market for a Drug Company's Secrets Is Its Own Bankruptcy
The OpenAI Foundation is funding a nonprofit to bid on failed biotech's FDA dossiers — regulatory files that cost millions to produce and change hands for roughly $25,000, sold by an estate with no confidentiality interest left to protect.